You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Central Nervous System Neoplasm

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Brain-Gut Axis and Gut Microbiome in Brain Lesions -

Not yet recruiting
  • Malignant Central Nervous System Neoplasm
  • Non-Interventional Study
  • Jacksonville, Florida
    Mayo Clinic in Florida
Oct 31, 2023

Seen on Brain Imaging in Pediatric Patients Following Proton

Recruiting
  • Malignant Central Nervous System Neoplasm
  • Malignant Skull Base Neoplasm
  • Medical Chart Review
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 6, 2023

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

Not yet recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
  • SC-CAR4BRAIN
  • Seattle, Washington
    Seattle Children's Hospital
Mar 3, 2023

Patients With Brain Tumors Undergoing Surgery

Recruiting
  • Central Nervous System Neoplasm
  • +3 more
  • Biospecimen Collection
  • Laboratory Biomarker Analysis
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 29, 2022

CNS Tumor, Cranial Nerve Disorder, Metastatic Malignant Tumor in the Brain Trial in Portland (Ferumoxytol, Gadolinium, Magnetic

Recruiting
  • Central Nervous System Neoplasm
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 2, 2022

High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

Recruiting
  • High Grade Glioma
  • +12 more
  • LUTATHERA® (Lutetium Lu 177 dotatate)
  • Aurora, Colorado
  • +8 more
Jan 16, 2023

Non-small Cell Lung Cancer With Central Nervous System

Recruiting
  • Lung Cancer With Central Nervous System Metastasis
  • lung cancer with brain /leptomeningeal metastasis
  • Taipei, Taiwan
    National Taiwan University Hospital
Sep 4, 2023

Malignant CNS Tumor Trial in Rochester (drug, other, procedure)

Not yet recruiting
  • Malignant Central Nervous System Neoplasm
  • Anhydrous Enol-oxaloacetate
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 31, 2023

Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Visual Pathway Glioma Trial in United

Completed
  • Neurofibromatosis Type 1
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Los Angeles, California
  • +11 more
Apr 22, 2022

Recurrent Lymphoma, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan,

Active, not recruiting
Has Results
  • Recurrent Lymphoma
  • +5 more
  • Birmingham, Alabama
  • +19 more
Oct 20, 2022

Sarcoma, Ovarian Tumor, CNS Tumor Trial in Villejuif (Pembrolizumab)

Active, not recruiting
  • Sarcoma
  • +6 more
  • Villejuif, France
    Gustave Roussy Cancer Campus
Mar 28, 2022

Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,

Completed
Has Results
  • Brain Stem Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +20 more
Jan 6, 2023

CNS Lymphoma, Secondary CNS Lymphoma Trial run by the National Cancer Institute (NCI) (TEDD-R, TEDDI-R, Ibrutinib)

Recruiting
  • Central Nervous System Lymphoma
  • Secondary Central Nervous System Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Diffuse Midline Glioma, H3 K27M-Mutant, Metastatic Malignant Tumor in the CNS, Recurrent Diffuse Intrinsic Pontine Glioma Trial

Active, not recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • +10 more
  • FACT Complex-targeting Curaxin CBL0137
  • Birmingham, Alabama
  • +19 more
Jun 29, 2022

Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)

Not yet recruiting
  • Primary Central Nervous System Lymphoma
  • +3 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022

Malignant CNS Tumor Trial in Atlanta (Intensity-Modulated Proton Therapy, Magnetic Resonance Imaging)

Active, not recruiting
  • Malignant Central Nervous System Neoplasm
  • Intensity-Modulated Proton Therapy
  • Magnetic Resonance Imaging
  • Atlanta, Georgia
  • +1 more
Feb 28, 2022

Constitutional Mismatch Repair Deficiency Syndrome, Hematopoietic and Lymphoid Cell Tumor, Lynch Syndrome Trial in Canada,

Withdrawn
  • Constitutional Mismatch Repair Deficiency Syndrome
  • +11 more
  • Biospecimen Collection
  • +2 more
  • Palo Alto, California
  • +8 more
Sep 9, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Scottsdale, Arizona
  • +2 more
Jan 4, 2023

Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in Beijing (GNC-038)

Recruiting
  • Primary Central Nervous System Lymphoma
  • Secondary Central Nervous System Lymphoma
  • Beijing, Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Jul 31, 2022

Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

Recruiting
  • Diffuse Midline Glioma (DMG)
  • +7 more
  • ONC206
  • Standard of Care Radiation Therapy
  • San Francisco, California
  • +2 more
Sep 13, 2022

Patient Perceptions Around Quality of Care Through Telemedicine

Recruiting
  • Central Nervous System Neoplasm
  • +3 more
  • Electronic Health Record Review
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
Nov 19, 2021

Breast Carcinoma, Digestive System Tumor, Malignant Brain Tumor Trial in Scottsdale, Jacksonville (Biospecimen Collection,

Active, not recruiting
  • Breast Carcinoma
  • +10 more
  • Biospecimen Collection
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Feb 17, 2022

Cerebrospinal Fluid Biomarkers for Brain Tumors

Recruiting
  • Central Nervous System Neoplasm
  • Biospecimen Collection
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 3, 2021

Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan

Active, not recruiting
  • Childhood Solid Neoplasm
  • +4 more
  • Irinotecan Hydrochloride
  • +4 more
  • Birmingham, Alabama
  • +20 more
Feb 1, 2023

Malignant CNS Tumor, Primary CNS Tumor Trial in Rochester (Cogstate Assessment Battery, Memantine, Memantine Hydrochloride)

Recruiting
  • Malignant Central Nervous System Neoplasm
  • Primary Central Nervous System Neoplasm
  • Cogstate Assessment Battery
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 21, 2021